Cubist Systematic Strategies, LLC Vbi Vaccines Inc Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.38 - $22.5 $2,424 - $143,527	6,379 Added 6714.74%	6,474 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $4,899 - $157,037	-6,711 Reduced 98.6%	95 $0
Q2 2022 Aug 15, 2022	SELL	$0.66 - $1.81 $2,428 - $6,658	-3,679 Reduced 35.09%	6,806 $6,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $13,195 - $25,663	10,390 Added 10936.84%	10,485 $17,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $31,435 - $45,801	-14,224 Reduced 99.34%	95 $0
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $40,093 - $53,266	14,319 New	14,319 $45,000
Q2 2021 Aug 16, 2021	SELL	$2.61 - $4.17 $115,101 - $183,897	-44,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $128,331 - $190,512	44,100 New	44,100 $137,000
Q3 2020 Nov 16, 2020	SELL	$2.77 - $6.17 $36,915 - $82,227	-13,327 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $11,594 - $41,713	13,327 New	13,327 $41,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.